Weilin Sang

817 total citations
28 papers, 644 citations indexed

About

Weilin Sang is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Weilin Sang has authored 28 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Rheumatology. Recurrent topics in Weilin Sang's work include Osteoarthritis Treatment and Mechanisms (8 papers), Orthopaedic implants and arthroplasty (6 papers) and Total Knee Arthroplasty Outcomes (6 papers). Weilin Sang is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Orthopaedic implants and arthroplasty (6 papers) and Total Knee Arthroplasty Outcomes (6 papers). Weilin Sang collaborates with scholars based in China, Germany and Australia. Weilin Sang's co-authors include Jinzhong Ma, Libo Zhu, Haiming Lu, Song Xue, Yafei Jiang, Yiming Xu, Yiming Zhong, Cong Wang, Chuanglong He and Xiaojun Zhou and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Weilin Sang

28 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weilin Sang China 12 291 165 140 121 101 28 644
Taro Matsuzaki Japan 15 299 1.0× 165 1.0× 153 1.1× 170 1.4× 107 1.1× 53 668
Jinzhong Ma China 11 274 0.9× 172 1.0× 126 0.9× 57 0.5× 88 0.9× 34 568
Weixu Li China 17 208 0.7× 113 0.7× 146 1.0× 76 0.6× 64 0.6× 51 672
Shijie Liao China 16 330 1.1× 67 0.4× 97 0.7× 169 1.4× 176 1.7× 69 690
Hongyi Jiang China 15 308 1.1× 69 0.4× 72 0.5× 91 0.8× 179 1.8× 52 642
Guojie Xu China 13 202 0.7× 82 0.5× 68 0.5× 123 1.0× 92 0.9× 17 510
Rina Andriamanalijaona France 10 234 0.8× 287 1.7× 178 1.3× 60 0.5× 148 1.5× 10 739
Xuexiao Ma China 16 315 1.1× 89 0.5× 247 1.8× 78 0.6× 199 2.0× 47 825
Baoqing Yu China 10 300 1.0× 127 0.8× 69 0.5× 42 0.3× 165 1.6× 14 612
Deye Song China 18 451 1.5× 68 0.4× 184 1.3× 81 0.7× 267 2.6× 45 860

Countries citing papers authored by Weilin Sang

Since Specialization
Citations

This map shows the geographic impact of Weilin Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilin Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilin Sang more than expected).

Fields of papers citing papers by Weilin Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilin Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilin Sang. The network helps show where Weilin Sang may publish in the future.

Co-authorship network of co-authors of Weilin Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Weilin Sang. A scholar is included among the top collaborators of Weilin Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilin Sang. Weilin Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Peng, Yichao Ma, Weilin Sang, et al.. (2025). Reprogramming Macrophage Phenotype Using a Reactive Oxygen Species-Responsive Liposome Delivery System for Inflammation Microenvironment Remodeling and Osteoarthritis Treatment. ACS Applied Materials & Interfaces. 17(12). 17932–17947. 6 indexed citations
2.
Chen, Hongjie, Yiming Zhong, Weilin Sang, et al.. (2024). Protopine protects chondrocytes from undergoing ferroptosis by activating Nrf2 pathway. Biochemical and Biophysical Research Communications. 710. 149599–149599. 5 indexed citations
3.
Sang, Weilin, et al.. (2023). Malposition is main cause of failure of Oxford mobile-bearing medial unicompartmental knee arthroplasty. Bone & Joint Open. 4(12). 914–922. 5 indexed citations
4.
Zhong, Yiming, Yiming Xu, Song Xue, et al.. (2022). Nangibotide attenuates osteoarthritis by inhibiting osteoblast apoptosis and TGF-β activity in subchondral bone. Inflammopharmacology. 30(3). 1107–1117. 8 indexed citations
6.
Xu, Yiming, Song Xue, Tian Zhang, et al.. (2022). Toddalolactone protects against osteoarthritis by ameliorating chondrocyte inflammation and suppressing osteoclastogenesis. Chinese Medicine. 17(1). 18–18. 7 indexed citations
7.
Sang, Weilin, Song Xue, Yafei Jiang, et al.. (2021). METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response. Life Sciences. 278. 119528–119528. 64 indexed citations
9.
Xue, Song, Xiaojun Zhou, Weilin Sang, et al.. (2021). Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy. Bioactive Materials. 6(8). 2372–2389. 160 indexed citations
10.
Wang, Congrong, et al.. (2021). [Electrospun PLGA scaffold loaded with osteogenic growth peptide accelerates cranial bone repair in rats].. PubMed. 41(8). 1183–1190. 1 indexed citations
11.
Xu, Yiming, Weilin Sang, Yiming Zhong, et al.. (2021). CoCrMo‐Nanoparticles induced peri‐implant osteolysis by promoting osteoblast ferroptosis via regulating Nrf2‐ARE signalling pathway. Cell Proliferation. 54(12). e13142–e13142. 36 indexed citations
12.
Shao, Qing, Song Xue, Yafei Jiang, et al.. (2020). Esculentoside A protects against osteoarthritis by ameliorating inflammation and repressing osteoclastogenesis. International Immunopharmacology. 82. 106376–106376. 18 indexed citations
13.
Xue, Song, Libo Zhu, Cong Wang, et al.. (2019). CDK9 attenuation exerts protective effects on catabolism and hypertrophy in chondrocytes and ameliorates osteoarthritis development. Biochemical and Biophysical Research Communications. 517(1). 132–139. 12 indexed citations
14.
Xue, Song, Qing Shao, Libo Zhu, et al.. (2019). LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo. International Immunopharmacology. 75. 105826–105826. 13 indexed citations
15.
Xu, Xun, et al.. (2018). Effect of Celecoxib on Surgical Site Inflammation after Total Knee Arthroplasty: A Randomized Controlled Study. Medical Principles and Practice. 27(5). 481–488. 6 indexed citations
16.
Jiang, Yafei, Libo Zhu, Tao Zhang, et al.. (2017). BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(12). 3001–3015. 63 indexed citations
17.
Zhu, Libo, Jinzhong Ma, Weilin Sang, et al.. (2017). [Mid-term effectiveness of total hip arthroplasty by direct anterior approach].. PubMed. 31(9). 1031–1035. 1 indexed citations
18.
Sang, Weilin, Libo Zhu, Jinzhong Ma, Haiming Lu, & Cong Wang. (2016). Lentivirus-Mediated Knockdown of CTHRC1 Inhibits Osteosarcoma Cell Proliferation and Migration. Cancer Biotherapy and Radiopharmaceuticals. 31(3). 91–98. 6 indexed citations
19.
Sang, Weilin, et al.. (2016). The Influence of Body Mass Index and Hip Anatomy on Direct Anterior Approach Total Hip Replacement. Medical Principles and Practice. 25(6). 555–560. 26 indexed citations
20.
Li, Fan, Weilin Sang, Qiugen Wang, Jianhua Huang, & Haimin Lu. (2011). Subtrochanteric Fracture Treatment: A Retrospective Study of 46 Patients. Medical Principles and Practice. 20(6). 519–524. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026